VivoSeq
Other

Veterans

3

Pipeline Programs

3

Active Trials

0

Companies Involved

Veterans is an early-stage landscape with 3 programs across 0 companies. 3 therapies are approved.

Pipeline Metrics

Competitive Density

25/100

Pipeline Velocity

6/100

Mech. Concentration

N/A

Completion Rate

73/100

Attrition Rate

14/100

Programs by Phase

Trial Status

14

clinical trials

Completed8 · 57%
Recruiting1 · 7%
Active, not recruiting1 · 7%
Terminated1 · 7%
Suspended1 · 7%
Withdrawn1 · 7%
Other1 · 7%

Trial Activity

14 trials

Telehealth-based Symptom Management for Veterans Treated With Selinexor
Active, not recruiting··N/A·NCT06452446·20 enrolled
Veterans Inpatient Insulin Study and Transition to Outpatient Therapy
Completed··Phase 4·NCT00821795·120 enrolled
Adjunctive Pregnenolone in Veterans With Mild TBI
Completed··N/A·NCT00623506·30 enrolled
Novel Intervention for Chronic Complex TBI in OEF/OIF/OND Veterans
Suspended··Phase 2·NCT05671692·108 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)